Study Name: TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis
29 locations found
- Study Name Unavailable
Location: Bakersfield, California
- Study Name Unavailable
Location: San Diego, California
- Study Name Unavailable
Location: Aurora, Colorado
- Study Name Unavailable
Location: Washington, District of Columbia
- Study Name Unavailable
Location: Jacksonville, Florida
- Study Name Unavailable
Location: West Palm Beach, Florida
- Study Name Unavailable
Location: Atlanta, Georgia
- Study Name Unavailable
Location: Crestview Hills, Kentucky
- Study Name Unavailable
Location: Florence, Kentucky
- Study Name Unavailable
Location: New Orleans, Louisiana
- Study Name Unavailable
Location: Chevy Chase, Maryland
- Study Name Unavailable
Location: Jackson, Mississippi
- Study Name Unavailable
Location: Tupelo, Mississippi
- Study Name Unavailable
Location: Kansas City, Missouri
- Study Name Unavailable
Location: Missoula, Montana
- Study Name Unavailable
Location: Newark, New Jersey
- Study Name Unavailable
Location: New York, New York
- Study Name Unavailable
Location: Rochester, New York
- Study Name Unavailable
Location: Cincinnati, Ohio
- Study Name Unavailable
Location: Cleveland, Ohio
- Study Name Unavailable
Location: Allentown, Pennsylvania
- Study Name Unavailable
Location: Philadelphia, Pennsylvania
- Study Name Unavailable
Location: Pittsburgh, Pennsylvania
- Study Name Unavailable
Location: Arlington, Texas
- Study Name Unavailable
Location: Odessa, Texas
- Study Name Unavailable
Location: San Antonio, Texas
- Study Name Unavailable
Location: Falls Church, Virginia
- Study Name Unavailable
Location: Bellevue, Washington
- Study Name Unavailable
Location: Seattle, Washington
|